about
Niche-specific requirement for hyphal wall protein 1 in virulence of Candida albicansDetection of urinary excreted fungal galactomannan-like antigens for diagnosis of invasive aspergillosisSpread ofCryptococcus gattiiinto Pacific Northwest Region of the United StatesImproved survival of mice deficient in secretory immunoglobulin M following systemic infection with Cryptococcus neoformansThe absence of serum IgM enhances the susceptibility of mice to pulmonary challenge with Cryptococcus neoformans.Phenotyping mouse pulmonary function in vivo with the lung diffusing capacity.Immunogenicity and efficacy of Cryptococcus neoformans capsular polysaccharide glucuronoxylomannan peptide mimotope-protein conjugates in human immunoglobulin transgenic mice.Towards a vaccine for Cryptococcus neoformans: principles and caveats.Therapeutic efficacy of a conjugate vaccine containing a peptide mimotope of cryptococcal capsular polysaccharide glucuronoxylomannanCryptococcus gattii: Emergence in Western North America: Exploitation of a Novel Ecological Niche.Immunotherapy of Fungal Infections.Short-term risk of liver and renal injury in hospitalized patients using micafungin: a multicentre cohort study.Urine Antigen Detection as an Aid to Diagnose Invasive Aspergillosis.Species-specific prevalence of vaginal candidiasis among patients with diabetes mellitus and its relation to their glycaemic statusSerotype distribution of Cryptococcus neoformans in patients in a tertiary care center in IndiaEfficacy of immune sera from human immunoglobulin transgenic mice immunized with a peptide mimotope of Cryptococcus neoformans glucuronoxylomannanCryptococcus gattii infection in healthy hosts: a sentinel for subclinical immunodeficiency?A Multicenter, Longitudinal Cohort Study of Cryptococcosis in Human Immunodeficiency Virus-negative People in the United States
P50
Q27301458-27988670-3820-42A8-9080-F8C19E6A5653Q28482168-8BFF520B-D520-478B-ABF8-4DCFB4ADEC3AQ30048584-E2CEB58A-287F-4500-8C0E-6BF8635EF39FQ33557968-56B19477-7EC7-4898-B342-D2D9F4A5291EQ33912345-510C33CC-C4EF-4B69-8EDC-04DE3F20D2A7Q35161835-F99790D5-9592-478D-968B-E9C786A78D46Q36228216-55C106F4-C83B-4435-AB0F-94F5575C02D8Q36476690-0E16C5F2-9171-4B05-A93C-D2F9FF48ED47Q36844895-1765E987-D7B7-4C5B-9F63-81B97DCEDA5EQ37111315-30E1E79E-77A9-4DE2-9DD9-6FE33AA528F2Q38635409-CBB7CA03-2941-450F-B394-17411F7BEF62Q40615864-5CAD2202-9F57-49E7-8656-E15F97B6498DQ54230302-49171BFB-4955-40E1-BF4D-13DCB4D17967Q73053675-6F722B90-425A-491E-91E6-D9D93A06A247Q80046401-8E34094C-FE05-448B-BB64-7C9F65B080E4Q80557046-855AA6EA-AAAF-42A0-897C-6C6A8172EFCDQ82465043-C82066EE-5207-497B-91EA-FEFDFE36CBC2Q95727640-ACB632F1-923A-4159-9B5D-A6B4BA763F87
P50
description
researcher ORCID ID = 0000-0001-8666-143X
@en
name
Kausik Datta
@ast
Kausik Datta
@en
Kausik Datta
@es
Kausik Datta
@nl
type
label
Kausik Datta
@ast
Kausik Datta
@en
Kausik Datta
@es
Kausik Datta
@nl
prefLabel
Kausik Datta
@ast
Kausik Datta
@en
Kausik Datta
@es
Kausik Datta
@nl
P1153
24528359600
P31
P496
0000-0001-8666-143X